OBJECTIVE: We evaluated the utility of adhesion molecule (AM) and cytokine/chemokine expressions in blood and cerebrospinal fluid (CSF) as markers of disease activity in primary progressive multiple sclerosis (PPMS). METHODS: The expressions of AMs and the levels of 17 cytokines in patients with PPMS (n = 25) were compared with those in secondary progressive MS (SPMS) (n = 18) and controls (n =11) and correlated with the volumes of focal and atrophic changes on MRI. RESULTS: The expressions of very late activation antigen 4 (VLA-4), lymphocyte function-associated antigen 1 (LFA-1) and intercellular adhesion molecule 1 (ICAM-1) in blood and CSF were higher in PPMS than in controls. Comparison between PPMS and SPMS showed higher levels of ICAM-1 in blood and CSF in PPMS, while the level of the vascular adhesion molecule (VCAM-1) was higher only in blood. There was no difference in the levels of cytokines in serum or CSF between PPMS and SPMS or controls, but evidence suggesting intrathecal synthesis of interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) was found in PPMS. The expressions of CSF VLA-4 in PPMS correlated with the total volume of cerebral lesions and the number of diffuse brain lesions in MRI, while the amount of LFA-1 in CSF correlated with the number of spinal T2 lesions. The level of serum MIP-1beta correlated with the T2 lesion load and EDSS score in PPMS. CONCLUSIONS: The upregulated expressions of AMs in blood and CSF and evidence for intrathecal synthesis of MCP-1 and IL-8 in PPMS indicate the importance of inflammatory changes in the pathogenesis of PPMS.
OBJECTIVE: We evaluated the utility of adhesion molecule (AM) and cytokine/chemokine expressions in blood and cerebrospinal fluid (CSF) as markers of disease activity in primary progressive multiple sclerosis (PPMS). METHODS: The expressions of AMs and the levels of 17 cytokines in patients with PPMS (n = 25) were compared with those in secondary progressive MS (SPMS) (n = 18) and controls (n =11) and correlated with the volumes of focal and atrophic changes on MRI. RESULTS: The expressions of very late activation antigen 4 (VLA-4), lymphocyte function-associated antigen 1 (LFA-1) and intercellular adhesion molecule 1 (ICAM-1) in blood and CSF were higher in PPMS than in controls. Comparison between PPMS and SPMS showed higher levels of ICAM-1 in blood and CSF in PPMS, while the level of the vascular adhesion molecule (VCAM-1) was higher only in blood. There was no difference in the levels of cytokines in serum or CSF between PPMS and SPMS or controls, but evidence suggesting intrathecal synthesis of interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) was found in PPMS. The expressions of CSF VLA-4 in PPMS correlated with the total volume of cerebral lesions and the number of diffuse brain lesions in MRI, while the amount of LFA-1 in CSF correlated with the number of spinal T2 lesions. The level of serum MIP-1beta correlated with the T2 lesion load and EDSS score in PPMS. CONCLUSIONS: The upregulated expressions of AMs in blood and CSF and evidence for intrathecal synthesis of MCP-1 and IL-8 in PPMS indicate the importance of inflammatory changes in the pathogenesis of PPMS.
Authors: Leyre Mestre; Paula M Iñigo; Miriam Mecha; Fernando G Correa; Miriam Hernangómez-Herrero; Frida Loría; Fabian Docagne; José Borrell; Carmen Guaza Journal: J Neuroinflammation Date: 2011-08-18 Impact factor: 8.322
Authors: Renuka Natarajan; Sanna Hagman; Xingchen Wu; Ullamari Hakulinen; Minna Raunio; Mika Helminen; Maija Rossi; Prasun Dastidar; Irina Elovaara Journal: Mult Scler Int Date: 2013-12-17
Authors: Gabriel Arellano; Eric Acuña; Lilian I Reyes; Payton A Ottum; Patrizia De Sarno; Luis Villarroel; Ethel Ciampi; Reinaldo Uribe-San Martín; Claudia Cárcamo; Rodrigo Naves Journal: Front Immunol Date: 2017-06-30 Impact factor: 7.561
Authors: Ahmed Abdelhak; Tilman Hottenrott; Christoph Mayer; Gudrun Hintereder; Uwe K Zettl; Oliver Stich; Hayrettin Tumani Journal: PLoS One Date: 2017-08-10 Impact factor: 3.240
Authors: Jeppe Romme Christensen; Lars Börnsen; Rikke Ratzer; Fredrik Piehl; Mohsen Khademi; Tomas Olsson; Per Soelberg Sørensen; Finn Sellebjerg Journal: PLoS One Date: 2013-03-01 Impact factor: 3.240
Authors: Adriana C Dos Santos; Ester Roffê; Rosa M E Arantes; Luiz Juliano; Jorge L Pesquero; João B Pesquero; Michael Bader; Mauro M Teixeira; Juliana Carvalho-Tavares Journal: J Neuroinflammation Date: 2008-11-05 Impact factor: 8.322